glp 1 agonist brands GLP-1 Medications for Weight Loss GLP-1 Receptor Agonist Market Size
Description
7.4 07 mpH/min
( Epub 20171030 )
As type 2 diabetes becomes a more common condition among women of reproductive age, and with the recent approval of GLP-1 receptor agonists such as semaglutide to treat obesity, the number of exposed pregnancies is likely to increase
( 10.1016/j.molmet.2022.101586) [DOI] [PMC free article] [PubMed] [Google Scholar] Pujadas G Varin EM Baggio LL Mulvihill EE Bang KWA Koehler JA Matthews D & Drucker DJ
The beneficial actions based on activation of the entero-insular axis are complex and multitargeted, involving the gut, brain, pancreas, and liver
P., Langhans, W
